SCHEMBL6438142

SCHEMBL6438142

CN1CCC(C(NC(=O)C(F)(F)F)c2ccc3cc(Cl)ccc3c2)CC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
F10 P00742 3/20 0.50
HRH4 Q9H3N8 2/20 0.42
HRH3 Q9Y5N1 2/20 0.42
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
AKT1 P31749 5/20 0.39
CDK2 P24941 1/20 0.39
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
SSTR4 P31391 1/20 0.38
ACACB O00763 1/20 0.38
CACNA2D1 P54289 1/20 0.37
CACNA1B Q00975 1/20 0.37
CACNB1 Q02641 1/20 0.37
CACNA1C Q13936 1/20 0.37
CCR8 P51685 2/20 0.37
HTR2A P28223 1/20 0.36
PRCP P42785 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6438144 0.81 DPP7 (0.46) F10HRH4HRH3CACNA2D1CACNA1B
SCHEMBL23216831 0.76 NPC1 (0.39) HRH4HRH3SSTR4CCR8
SCHEMBL29745153 0.76 NPC1 (0.39) HRH4HRH3SSTR4CCR8
SCHEMBL6433159 0.74 HRH4 (0.49) F10HRH4HRH3MEN1KMT2A
SCHEMBL4432685 0.71 AKT1 (0.42) MEN1KMT2AAKT1CACNA2D1CACNA1B
SCHEMBL29745505 0.71 HTR4 (0.39) KMT2ASSTR4
SCHEMBL23214819 0.71 HTR4 (0.39) KMT2ASSTR4
SCHEMBL13476462 0.70 SLC6A3 (0.52) AKT1CDK2
SCHEMBL17149869 0.69 HRH4 (0.58) HRH4HRH3
SCHEMBL27999710 0.68 POLB (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042287-B1 INDOLE DERIVATIVES AS INHIBITORS OF FACTOR XA AVENTIS PHARMA GMBH (DE) 2005-04-20 EP disclosed
US-6337344-B1 ANTICOAGULANTS AND ENZYME INHIBITORS FOR CARDIOVASCULAR DISORDERS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-01-08 US disclosed
EP-1042287-A1 INDOLE DERIVATIVES AS INHIBITORS OF FACTOR XA Aventis Pharma Deutschland GmbH (DE) 2000-10-11 EP disclosed
WO-1999033800-A1 INDOLE DERIVATIVES AS INHIBITORS OR FACTOR XA AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 1999-07-08 WO disclosed